Boyang Yu Selected Research

L-Lactate Dehydrogenase (Lactate Dehydrogenase)

4/2020	Metabolomic profiling of metoprolol-induced cardioprotection in a murine model of acute myocardial ischemia.
12/2016	YiQiFuMai Powder Injection Attenuates Ischemia/Reperfusion-Induced Myocardial Apoptosis Through AMPK Activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Boyang Yu Research Topics

Disease

15	Inflammation (Inflammations) 03/2024 - 07/2005
13	Neoplasms (Cancer) 01/2022 - 11/2010
12	Myocardial Ischemia (Ischemic Heart Diseases) 04/2024 - 11/2016
12	Brain Ischemia (Cerebral Ischemia) 01/2022 - 06/2008
11	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 03/2011
9	Thrombosis (Thrombus) 03/2024 - 06/2006
9	Reperfusion Injury 12/2021 - 06/2008
8	Heart Failure 04/2024 - 05/2016
8	Infarction (Infarctions) 10/2022 - 08/2013
8	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 08/2013
7	Acute Lung Injury 02/2024 - 01/2012
6	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2009
6	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2010
6	Ischemia 11/2018 - 03/2005
4	Fibrosis (Cirrhosis) 12/2022 - 03/2019
4	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 09/2005
4	Edema (Dropsy) 08/2016 - 07/2005
3	Pheochromocytoma 01/2022 - 01/2016
3	type 2C Congenital disorder of glycosylation 01/2022 - 01/2017
3	Hypersensitivity (Allergy) 01/2022 - 01/2018
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022 - 01/2016
3	Myocardial Infarction 01/2021 - 01/2019
3	Brain Infarction 08/2016 - 06/2008
3	Sepsis (Septicemia) 08/2016 - 08/2006
3	Pulmonary Edema 08/2016 - 01/2012
3	Hypoxia (Hypoxemia) 04/2013 - 01/2010
2	Infections 03/2024 - 10/2021
2	Lung Injury 02/2024 - 01/2022
2	COVID-19 07/2023 - 10/2021
2	Parkinson Disease (Parkinson's Disease) 01/2023 - 12/2009
2	Dysmenorrhea (Menstrual Pain) 05/2022 - 10/2020
2	Brain Injuries (Brain Injury) 01/2021 - 01/2021
2	Ischemic Stroke 01/2020 - 01/2017
2	Herpes Zoster 01/2020 - 01/2016
2	Pain (Aches) 01/2019 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 01/2017
2	Leukemia 09/2017 - 09/2011
2	Anaphylaxis (Anaphylactic Shock) 09/2017 - 01/2017

Drug/Important Bio-Agent (IBA)

14	ruscogeninIBA 11/2023 - 07/2005
13	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2010
10	radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)IBA 01/2022 - 12/2015
8	Oxygen (Dioxygen)IBA 03/2022 - 01/2016
8	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 01/2016
8	yi-qi-fu-maiIBA 01/2022 - 01/2016
8	SaponinsIBA 01/2020 - 12/2006
7	LipopolysaccharidesIBA 03/2024 - 05/2008
7	Neuroprotective AgentsIBA 01/2022 - 10/2014
7	PowdersIBA 01/2020 - 01/2016
6	Therapeutic UsesIBA 04/2024 - 01/2020
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2020 - 09/2005
6	Thromboplastin (Tissue Factor)IBA 02/2020 - 01/2010
5	blebbistatinIBA 01/2022 - 07/2015
4	ginsenoside Rb1IBA 03/2022 - 12/2015
4	Myosin Type IIIBA 01/2022 - 01/2017
4	Hematoxylin (Haematoxylon)IBA 01/2021 - 03/2019
4	Evans Blue (Blue, Evans)FDA Link 01/2021 - 06/2008
4	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 03/2019
4	CarrageenanIBA 05/2008 - 07/2005
3	Biomarkers (Surrogate Marker)IBA 03/2024 - 05/2016
3	ginsenoside RdIBA 10/2023 - 01/2017
3	schizandrinIBA 01/2021 - 12/2015
3	NF-kappa B (NF-kB)IBA 01/2021 - 06/2008
3	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2021 - 07/2015
3	Messenger RNA (mRNA)IBA 01/2018 - 01/2010
3	ophiopogonin DIBA 07/2015 - 07/2005
2	Pathogen-Associated Molecular Pattern MoleculesIBA 03/2024 - 01/2022
2	HMGB1 Protein (HMG1)IBA 03/2024 - 12/2021
2	Peptides (Polypeptides)IBA 03/2024 - 11/2017
2	Small Interfering RNA (siRNA)IBA 10/2023 - 01/2010
2	Particulate MatterIBA 07/2023 - 12/2018
2	Polysaccharides (Glycans)IBA 05/2023 - 01/2022
2	AdipokinesIBA 01/2023 - 10/2022
2	Oxytocin (Pitocin)FDA LinkGeneric 05/2022 - 01/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 02/2016
2	TriterpenesIBA 01/2022 - 01/2020
2	CateninsIBA 01/2022 - 05/2019
2	AcidsIBA 10/2021 - 05/2016
2	Anti-Allergic Agents (Antiallergic Agents)IBA 10/2021 - 01/2020
2	triphenyltetrazoliumIBA 01/2021 - 01/2021
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2020
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2020 - 12/2016
2	Creatine Kinase (Creatine Phosphokinase)IBA 04/2020 - 12/2016
2	CytokinesIBA 02/2020 - 08/2016
2	CollagenIBA 03/2019 - 07/2002
2	Cadherins (E-Cadherin)IBA 03/2019 - 09/2011
2	Interleukin-6 (Interleukin 6)IBA 03/2019 - 05/2013
2	corydalmineIBA 01/2019 - 01/2018
2	Dynamins (Dynamin)IBA 01/2019 - 01/2017
2	SolutionsIBA 11/2018 - 01/2017
2	Nonmuscle Myosin Type IIAIBA 11/2018 - 01/2016
2	Interleukin-8 (Interleukin 8)IBA 01/2018 - 06/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 05/2008
2	Hexosaminidases (Hexosaminidase)IBA 09/2017 - 01/2017

Therapy/Procedure

15	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 08/2006
6	Ligation 04/2024 - 09/2005
5	Therapeutics 03/2024 - 01/2012
5	Oral Administration 08/2016 - 09/2005
3	Drug Therapy (Chemotherapy) 01/2022 - 02/2016
3	Intravenous Injections 08/2016 - 01/2012
2	Ischemic Postconditioning 12/2021 - 11/2016